Total dose infusion iron dextran therapy in predialysis chronic renal failure patients

Renal Failure

Volumn 24, Issue 3, 2002, Pages 307-313

  Anuradha, S ^b   Singh, N P ^a   Agarwal, S K ^a  

^a G B PANT HOSPITAL   (India)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; HEMOGLOBIN; IRON DEXTRAN; BIOLOGICAL MARKER; CREATININE;

ADULT; ANEMIA; ARTHRALGIA; ARTICLE; BRONCHOSPASM; CHILL; CHRONIC KIDNEY FAILURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSPNEA; FEMALE; FERRITIN BLOOD LEVEL; FEVER; FLUSHING; HEADACHE; HEMODIALYSIS; HEMOGLOBIN DETERMINATION; HUMAN; IRON DEFICIENCY; IRON STORAGE; IRON THERAPY; MAJOR CLINICAL STUDY; MALE; MYALGIA; NAUSEA; PRIORITY JOURNAL; SIDE EFFECT; VOMITING; ADOLESCENT; BLOOD; BLOOD PRESSURE; CLINICAL TRIAL; COMPARATIVE STUDY; DIASTOLE; DOSE RESPONSE; DRUG EFFECT; DRUG SCREENING; INDIA; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; MIDDLE AGED; PHYSIOLOGY; RENAL REPLACEMENT THERAPY; SAFETY; SYSTOLE; TIME; TREATMENT OUTCOME;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; BLOOD PRESSURE; COMPARATIVE STUDY; CREATININE; DIASTOLE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION; FEMALE; FERRITIN; HEMOGLOBINS; HUMAN; INDIA; INFUSIONS, INTRAVENOUS; IRON-DEXTRAN COMPLEX; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGE; RENAL DIALYSIS; SAFETY; SUPPORT, NON-U.S. GOV'T; SYSTOLE; TIME FACTORS; TREATMENT OUTCOME; FERRITINS; HUMANS; MIDDLE AGED;

EID: 0036022105     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.1081/JDI-120005364     Document Type: Article

References (16)

1. Improved physical performance after treatment of renal anemia with recombinant human erythropoietin
2. The cardiovascular and hemodynamic effects of erythropoietin in chronic renal failure
3. Long-term cardio-respiratory effects of amelioration of renal anemia by erythropoietin
4. Importance of Iron Supply for Erythropoietin Therapy
5. Intra venous ferric saccharate as an iron supplement in dialysis patients
6. Regular low-dose intravenous iron therapy improves response erythropoietin in hemodialysis patients
7. Hematologic and erythropoietin responses to iron dextran in the hemodialysis environment
8. Iron management during recombinant human erythropoietin therapy
9. An evaluation of the effectiveness of oral iron therapy in hemodialysis patients receiving recombinant human erythropoietin
10. Low iron absorption in erythropoietin-treated hemodialysis patients
11. Iron absorption in patients with chronic uremia on maintenance hemodialysis and in healthy volunteers measured with a simple oral iron load test
12. NKF-DOQI clinical practice guidelines for the treatment of anemia of chronic renal failure
13. Efficacy of oral iron therapy in patients receiving recombinant human erythropoietin
14. Nutrition and health
15. Intravenous iron dextran treatment in predialysis patients with chronic renal failure
16. Total dose iron infusion: Safety and efficacy in predialysis patients